Shane Thomas Gleason - 15 Jan 2026 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Role: Chief Commercial Officer
Signature: /s/ Michael Lawless, Attorney-in-Fact for Shane Gleason
Issuer symbol: NSPR
Transactions as of: 15 Jan 2026
Net transactions value: -$99,331
Form type: 4
Filing time: 02 Feb 2026, 17:01:41 UTC
Previous filing: 16 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gleason Shane Thomas	Chief Commercial Officer	C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI	/s/ Michael Lawless, Attorney-in-Fact for Shane Gleason	02 Feb 2026	0001966214

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NSPR	Common Stock	Sale	$4,593	-2,909	-0.24%	$1.58	1,197,462	15 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$3,627	-2,250	-0.19%	$1.61	1,195,212	16 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$4,710	-2,955	-0.25%	$1.59	1,192,257	20 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$28,553	-17,593	-1.5%	$1.62	1,174,664	21 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$13,239	-8,411	-0.72%	$1.57	1,166,253	22 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$7,956	-4,781	-0.41%	$1.66	1,161,472	27 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$20,464	-12,395	-1.1%	$1.65	1,149,077	28 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$8,250	-5,000	-0.44%	$1.65	1,144,077	29 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$4,730	-2,900	-0.25%	$1.63	1,141,177	30 Jan 2026	Direct	F1
transaction	NSPR	Common Stock	Sale	$3,208	-2,000	-0.18%	$1.60	1,139,177	02 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.

Content

The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.

Remarks:

Exhibit 24.1: Power of Attorney